Takayoshi Kato

发表

Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytes.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2014, Biochemical and biophysical research communications.

Dantrolene prevents ventricular tachycardia by stabilizing the ryanodine receptor in pressure- overload induced failing hearts.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2019, Biochemical and biophysical research communications.

Impact of Atrial Tachyarrhythmia Recurrence on the Development of Long‐Term Adverse Clinical Events Following Catheter Ablation in Patients With Atrial Fibrillation With Systolic Impairment: A Single‐Center Observational Study

M. Yano, Shigeki Kobayashi, M. Ono, 2022, Journal of the American Heart Association.

Stabilizing cardiac ryanodine receptor prevents the development of cardiac dysfunction and lethal arrhythmia in Ca2+/calmodulin-dependent protein kinase IIδc transgenic mice.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2020, Biochemical and biophysical research communications.

Inferior J waves in patients with vasospastic angina might be a risk factor for ventricular fibrillation.

M. Yano, M. Ono, T. Okamura, 2017, Journal of cardiology.

Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2019, JCI insight.

Correction of impaired calmodulin binding to RyR2 as a novel therapy for lethal arrhythmia in the pressure-overloaded heart failure.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2017, Heart rhythm.

The Differential Prognostic Impact of Long-Duration Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices between Patients with and without a History of Atrial Fibrillation

M. Yano, Shigeki Kobayashi, M. Ono, 2022, Journal of clinical medicine.

Long‐term events following catheter‐ablation for atrial fibrillation in heart failure with preserved ejection fraction

M. Yano, Shigeki Kobayashi, T. Okamura, 2022, ESC heart failure.

Mutation-linked, excessively tight interaction between the calmodulin binding domain and the C-terminal domain of the cardiac ryanodine receptor as a novel cause of catecholaminergic polymorphic ventricular tachycardia.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2018, Heart rhythm.

Nonbacterial thrombotic endocarditis demonstrated by repeat echocardiography

M. Matsuzaki, H. Ogawa, Takayoshi Kato, 2013, Journal of Medical Ultrasonics.

An impact of superior vena cava isolation in non‐paroxysmal atrial fibrillation patients with low voltage areas

M. Yano, Shigeki Kobayashi, M. Ono, 2021, Journal of arrhythmia.

CaMKII-mediated phosphorylation of RyR2 plays a crucial role in aberrant Ca2+ release as an arrhythmogenic substrate in cardiac troponin T-related familial hypertrophic cardiomyopathy.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2018, Biochemical and biophysical research communications.

Distal radial arterial hypertrophy after transradial intervention: A serial intravascular ultrasound study.

Hiroshi Ogawa, Nozomu Harada, Takahiro Iwami, 2018, Journal of cardiology.

A Low-Dose β1-Blocker in Combination with Milrinone Improves Intracellular Ca2+ Handling in Failing Cardiomyocytes by Inhibition of Milrinone-Induced Diastolic Ca2+ Leakage from the Sarcoplasmic Reticulum

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2015, PloS one.

Enhancing calmodulin binding to cardiac ryanodine receptor completely inhibits pressure-overload induced hypertrophic signaling

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2020, Communications biology.

Recombinant Atrial Natriuretic Peptide Prevents Aberrant Ca2+ Leakage through the Ryanodine Receptor by Suppressing Mitochondrial Reactive Oxygen Species Production Induced by Isoproterenol in Failing Cardiomyocytes

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2016, PloS one.

Oxidation of ryanodine receptor (RyR) and calmodulin enhance Ca release and pathologically alter, RyR structure and calmodulin affinity.

D. Bers, David D. Thomas, M. Yano, 2015, Journal of molecular and cellular cardiology.

Enhancing calmodulin binding to cardiac ryanodine receptor completely inhibits pressure-overload induced hypertrophic signaling

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2020, Communications Biology.

Enhanced binding of calmodulin to the ryanodine receptor corrects contractile dysfunction in failing hearts.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2012, Cardiovascular research.

Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design

K. Kario, N. Kitamura, Y. Nakajima, 2020, Diabetes Therapy.

Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin.

D. Bers, M. Yano, Shigeki Kobayashi, 2018, Journal of molecular and cellular cardiology.

Stabilization of RyR2 maintains right ventricular function, reduces the development of ventricular arrhythmias, and improves prognosis in pulmonary hypertension.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2022, Heart rhythm.

Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytes.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2014, Biochemical and biophysical research communications.

Incidence of Mid-Term Prognostic Events in Patients With Acute Coronary Syndrome During the Late 2010s in 2 Tertiary Hospitals in a Rural Area of Japan　― A Temporal Comparison ―

K. Tanabe, M. Yano, Shigeki Kobayashi, 2023, Circulation reports.